REPORT HIGHLIGHT

The white biotechnology (COVID 19 Impact Analysis Updated Edition) market is estimated to represent a global market of USD 260.4 billion by 2019 with the growth rate of 8.9%.


Market Dynamics

Industrial applications of biotechnology hold many promises for sustainable development. Branch of biotechnology that “uses living cells- from enzymes, yeast, plants, and bacteria to synthesize novel products that require less energy consumption, easily degradable and create less waste during production” is referred as White Biotechnology. Development of this industry is, at present, driven by the growing acceptance of new technology trends such as bioprocess modelling and metabolic modelling. Furthermore, growing awareness regarding environmental and functional benefits of using biofuel in developed and developing economies is predicted to be the major driver for the growth of white biotechnology market.

In addition, factors such as growing demand for bioplastics, favourable government policies, constant research, and innovation to develop effective and high-quality API and cost reduction in production process augment the industry growth significantly. Regulatory authorities are continually striving to improve predictability and efficiency for the future products of biotechnology through their constant efforts. Governments in the U.S., China, Brazil, South East Asia, India, and European countries have implemented several favourable policies of tax reduction and fiscal incentives to promote the white biotechnology applications. For instance, the Executive Office of the President (EOP) introduced a memorandum, on July 2, 2015, directing the primary agencies that regulate the products of biotechnology to update the Coordinated Framework for the Regulation of Biotechnology. The agency is constantly engaged in developing a long-term strategy to ensure that the Federal biotechnology regulatory system is prepared to strengthen the future landscape of biotechnology products.

Product Takeaway

Based on products, the market is divided as Biomaterials, Biofuels, Industrial Enzymes, and Biochemical. Biofuels and biochemical are the largest revenue generating segment. In 2017, these segments have captured more than 70% revenue share of the worldwide white biotechnology industry revenue. Furthermore, the unstable price of conventional fuels such as natural gas, natural oil, and coal has created a prospective opportunity for these segments.

Application Takeaway

The industry finds wide applications in food & feed additive, bioenergy, pharmaceutical ingredients, personal care, and household products. Among which, bioenergy is expected to be the leading application as it eliminates the detrimental environmental effects of fossil-based fuel. Furthermore, the pharmaceutical industry extensively employs white biotechnology in order to develop antibodies, active pharmaceutical ingredients (API), and other complex biomolecules. This segment is anticipated to capture more than 20% revenue share of the global market throughout the study period.

Regional Takeaway

Regionally, North America accounted for the highest revenue share, i.e. 35.23% of the global market in 2017. Functional efficiency, environmental sustainability coupled with easy availability of raw materials are the key factors, stimulating the regional growth. On another hand, Asia Pacific has emerged as a major player in the white biotechnology market in the recent past along with North America and Europe. A large number of developing countries in the Asia Pacific (such as India, Thailand, Philippines, Colombia, Vietnam, etc.) have implemented the law of mandatory blending of biofuel in recent years. Furthermore, many Asia Pacific countries are aiming to increase the blending limit in the coming years. This would, in turn, is predicted to stimulate the demand for biofuel in the future, driving the overall industry growth.

Key Vendor Takeaway

Key players namely BioAmber, Amyris, BASF, Codexis, Evolva, Deinove, Novozymes, Metabolic Explorer, and Solazyme are profiled extensively. These companies are engaged in manufacturing a variety of biomaterials, biofuels, biochemicals and industrial enzymes. Industry rivalry among these players is high. Companies are aggressively investing in research and development activities to expand their product offering and production capabilities, thereby sustaining their market positions. For instance, Royal DSM opened its research and technology center for engineering plastics in Pune, India recently in April 2016. The company aims to support new product and application development through such expansion.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018
Base Year – 2019
Estimated Year – 2020
Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.


SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

WHITE BIOTECHNOLOGY MARKET, BY PRODUCT
Biomaterials
Biofuels
Industrial Enzymes
Biochemical

WHITE BIOTECHNOLOGY MARKET, BY APPLICATION
Food & Feed Additive
Bioenergy
Pharmaceutical Ingredients
Personal Care
Household Products


WHITE BIOTECHNOLOGY MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America